Imvax

active

Philadelphia, PA, United States

Founded 2015

About

Personalized Vaccines, Immunotherapy

Areas of Focus

Categories

Stem Cell & Cellular TherapyNJ, NY, PA

Team (17)

David G. Bunning

David W. Andrews, M.D.

John M. Limongelli

View all 17 team members →

Clinical Trials (1)

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

93

By Phase

PHASE2: 1

By Status

ACTIVE_NOT_RECRUITING: 1

Clinical Trials Pipeline1 trial

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2022

2023

2024

2025

2026

2027

2028

Today

Hover over trial bars to see details

Recent Trials

NCT04485949Lead Sponsor

A Phase 2b Clinical Study With a Combination Immunotherapy in Newly Diagnosed Patients With Glioblastoma

PHASE2Active, not recruiting

93 participants

Started: Mar 20, 2023 · Completed: Jul 31, 2027

Funding History (3)

D

Jul 30, 2020

D

May 28, 2019

D

Jun 16, 2017

Locations (1)

Headquarters

Philadelphia, PA, United States

Map

Loading map...